Folgen
Michael Nagler
Michael Nagler
Department of Clinical Chemistry, Inselspital, Bern University Hospital, and University of Berne
Bestätigte E-Mail-Adresse bei insel.ch
Titel
Zitiert von
Zitiert von
Jahr
Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis
M Nagler, LM Bachmann, H Ten Cate, A ten Cate-Hoek
Blood, The Journal of the American Society of Hematology 127 (5), 546-557, 2016
1482016
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19-a Swiss consensus statement by the Working Party Hemostasis
A Casini, L Alberio, A Angelillo-Scherrer, P Fontana, B Gerber, L Graf, ...
Swiss medical weekly 150, w20247, 2020
1252020
Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings
S Jegerlehner, F Suter-Riniker, P Jent, P Bittel, M Nagler
International Journal of Infectious Diseases 109, 118-122, 2021
1102021
Fondaparinux–data on efficacy and safety in special situations
M Nagler, M Haslauer, WA Wuillemin
Thrombosis research 129 (4), 407-417, 2012
1012012
A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon
M Nagler, P Keller, D Siegrist, L Alberio
BMC Clinical Pathology 14, 1-4, 2014
782014
Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with st-segment–elevation myocardial infarction: primary results of the FABOLUS-FASTER trial
G Gargiulo, G Esposito, M Avvedimento, M Nagler, P Minuz, G Campo, ...
Circulation 142 (5), 441-454, 2020
722020
Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia
M Nagler, T Bakchoul
Thrombosis and haemostasis 116 (11), 823-834, 2016
632016
Heparin-induced thrombocytopenia in cardiac surgery patients
AM Pishko, A Cuker
Seminars in thrombosis and hemostasis 43 (07), 691-698, 2017
592017
Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: normal values and variability
S Calzavarini, J Brodard, C Quarroz, L Maire, R Nützi, J Jankovic, ...
Research and practice in thrombosis and haemostasis 3 (4), 758-768, 2019
532019
Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders
M Adler, J Kaufmann, L Alberio, M Nagler
Journal of thrombosis and haemostasis 17 (7), 1104-1112, 2019
522019
Thromboembolism in patients with congenital afibrinogenaemia
M Nagler, JAK Hovinga, L Alberio, K Peter-Salonen, H von Tengg-Kobligk, ...
Thrombosis and haemostasis 116 (10), 722-732, 2016
452016
Prospective evaluation of the interobserver reliability of the 4Ts score in patients with suspected heparin‐induced thrombocytopenia
M Nagler, T Fabbro, WA Wuillemin
Journal of Thrombosis and Haemostasis 10 (1), 151-152, 2012
432012
Impact of rivaroxaban on point-of-care assays
P Fontana, L Alberio, A Angelillo-Scherrer, LM Asmis, W Korte, A Mendez, ...
Thrombosis research 153, 65-70, 2017
412017
Impact of changes in haematocrit level and platelet count on thromboelastometry parameters
M Nagler, S Kathriner, LM Bachmann, WA Wuillemin
Thrombosis Research 131 (3), 249-253, 2013
412013
Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study
M Nagler, LM Bachmann, P Schmid, P Raddatz Müller, WA Wuillemin
PloS one 9 (4), e95761, 2014
382014
Accuracy of serological testing for SARS‐CoV‐2 antibodies: first results of a large mixed‐method evaluation study
D Brigger, MP Horn, LF Pennington, AE Powell, D Siegrist, B Weber, ...
Allergy 76 (3), 853-865, 2021
362021
Association of anemia and hemoglobin decrease during acute stroke treatment with infarct growth and clinical outcome
S Bellwald, R Balasubramaniam, M Nagler, MS Burri, SDA Fischer, ...
PloS one 13 (9), e0203535, 2018
362018
Epistaxis in anticoagulated patients: Fewer hospital admissions and shorter hospital stays on rivaroxaban compared to phenprocoumon
TC Sauter, K Hegazy, WE Hautz, G Krummrey, ME Ricklin, M Nagler, ...
Clinical otolaryngology 43 (1), 103-108, 2018
352018
Comparative effectiveness and safety of anticoagulants for the treatment of heparin‐induced thrombocytopenia
H Nilius, J Kaufmann, A Cuker, M Nagler
American journal of hematology 96 (7), 805-815, 2021
342021
Accuracy and consistency of anti‐Xa activity measurement for determination of rivaroxaban plasma levels
JD Studt, L Alberio, A Angelillo‐Scherrer, LM Asmis, P Fontana, W Korte, ...
Journal of thrombosis and haemostasis 15 (8), 1576-1583, 2017
302017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20